Table 1.
Personal and family history of cancer in BRCA1 and BRCA2 mutation carriers.
| Patients with available history, n = 31 | Cancer type | Personal history, n (%) | Familial history, n (%) |
|---|---|---|---|
| BRCA1 | Breast | 16 (51.6) | 28 (90.3) |
| Colon | 1 (3.2) | 4 (12.9) | |
| Esophageal | 0 | 1 (3.2) | |
| Gastric | 0 | 1 (3.2) | |
| Leukemia | 0 | 1 (3.2) | |
| Lung | 0 | 4 (12.9) | |
| Melanoma | 0 | 1 (3.2) | |
| Ovarian | 2 (6.5) | 14 (45.2) | |
| Pancreatic | 1 (3.2) | 0 | |
| Prostate | 0 | 4 (12.9) | |
| Renal | 0 | 0 | |
|
| |||
| Patients with available history, n = 25 | Cancer type | Personal history, n (%) | Familial history, n (%) |
|
| |||
| BRCA2 | Breast | 6 (24.0) | 22 (88.0) |
| Colon | 0 | 6 (24.0) | |
| Esophageal | 0 | 0 | |
| Gastric | 0 | 2 (8.0) | |
| Leukemia | 0 | 0 | |
| Lung | 0 | 2 (8.0) | |
| Melanoma | 0 | 1 (4.0) | |
| Ovarian | 2 (8.0) | 12 (48.0) | |
| Pancreatic | 1 (4.0) | 4 (16.0) | |
| Prostate | 0 | 2 (8.0) | |
| Renal | 0 | 2 (8.0) | |